← 홈

ADC · 폐암 (NSCLC)

112개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 112개
ADCBiologicstaleShanghai Junshi Bioscience Co.,…Phase 2

JS212 (JS212)

Non-squamous Non-small Cell Lung Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 7상태 RECRUITING
ADCBiologicstaleBase Therapeutics (Shanghai) Co…Phase 2

NK510 (NK510)

NSCLC · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 1

AZD7789 (AZD7789)

Advanced or Metastatic NSCLC · Advanced or Metastatic NSCLC

#AdvancedorMetastaticNSCLC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 5상태 RECRUITING
ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

sigvotatug vedotin (sigvotatug vedotin)

Carcinoma, Non-Small Cell Lung; Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small Cell Lung

#CarcinomaNon-SmallCellLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 5상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

5-hydroxytryptamine subtype 3 receptor antagonist (5-hydroxytryptamine subtype 3 receptor antagonist)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 4상태 RECRUITING
ADCBiologicstaleMultitude Therapeutics Inc.Phase 2

AMT-116 (AMT-116)

Advanced Non-small Cell Lung Cancer (NSCLC) · Advanced Non-small Cell Lung Cancer (NSC

#AdvancedNon-smallCellLungCancerN#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 3

BNT324 (BNT324)

Advanced Lung Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
ADCBiologicstaleBristol-Myers SquibbPhase 2

MORAb-202 (MORAb-202)

Carcinoma, Non-Small-Cell Lung · Neoplasms, Ovarian

#NeoplasmsOvarian#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 20%임상시험 4상태 DISCONTINUED
ADCBiologicstaleBioAtla, Inc.Phase 2

CAB-ROR2-ADC (CAB-ROR2-ADC)

Non Small Cell Lung Cancer; Triple Negative Breast Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicstaleGenentech, Inc.Phase 2

DNIB0600A (DNIB0600A)

Non-Squamous Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer, Ovarian Canc

#Non-SmallCellLungCancerOvarianCa#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicstaleHarpoon Therapeutics, Inc., a s…Phase 2

Gocatamig (Gocatamig)

Small-Cell Lung Cancer; Neuroendocrine Carcinoma · Small-Cell Lung Cancer

#Small-CellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD0171 (AZD0171)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 34.9%임상시험 2상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT326 (BNT326)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleEnliven TherapeuticsPhase 1

ELVN-002 (ELVN-002)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstalePfizerPhase 3

PF-08046054 (PF-08046054)

Non-small Cell Carcinoma; Non-Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

#Non-smallCellCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleGlaxoSmithKlinePhase 1

Ris-Rez (Ris-Rez)

Neoplasms · Neoplasms, Lung

#NeoplasmsLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 1

SEA-TGT (SEA-TGT)

Non-small Cell Lung Cancer; Gastric Carcinoma · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 33.3%임상시험 2상태 DISCONTINUED
ADCBiologicstale3H Pharmaceuticals Co., Ltd.Phase 2

3H-10000 (3H-10000)

Lung Cancer; Stomach Cancer · Lung Cancer

#LungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleThe Netherlands Cancer InstitutePhase 2

89Zr-Patritumab deruxtecan (89Zr-Patritumab deruxtecan)

Non-Small Cell Lung Carcinoma; Advanced Non-Small Cell Squamous Lung Cancer · EGFR

#EGFR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleAbbViePhase 1

ABBV-221 (ABBV-221)

Head and Neck Squamous Cell Carcinoma; Non-small Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma

#HeadandNeckSquamousCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED

4 / 6 페이지

← 이전다음 →